ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,147, issued on Nov. 18, was assigned to Theriva Biologics Inc. (Rockville, Md.).
"Intestinal alkaline phosphatase formulations" was invented by Andrew Bristol (Rockville, Md.), Ray Stapleton (Rockville, Md.), Michael Kaleko (Rockville, Md.), Christian Furlan Freguia (Rockville, Md.), Steven Hubert (Rockville, Md.), Cristina Freire (Rockville, Md.) and James Gubbins (Rockville, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides for a formulation comprising an active alkaline phosphatase (AP)-based agent and an enteric agent, wherein the formulation is suitable for releasing a substantial amount of the active AP-based ag...